Last reviewed · How we verify

Paracetamol + Codeine

Ullevaal University Hospital · FDA-approved active Small molecule

Paracetamol reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system, while codeine is an opioid agonist that enhances analgesia through mu-receptor activation.

Paracetamol reduces pain and fever through inhibition of prostaglandin synthesis, while codeine is an opioid agonist that enhances analgesia through central nervous system depression. Used for Mild to moderate pain, Postoperative pain, Headache and migraine.

At a glance

Generic nameParacetamol + Codeine
Also known asParacetamol (Acetaminophen), ATC code: N02B E01, Codeine, ATC code: R05D A04
SponsorUllevaal University Hospital
Drug classAnalgesic combination (non-opioid + weak opioid)
TargetCyclooxygenase (COX) enzymes; mu opioid receptor
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Paracetamol (acetaminophen) works primarily through inhibition of cyclooxygenase enzymes in the brain and spinal cord, reducing prostaglandin production and thereby lowering pain perception and body temperature set point. Codeine is a weak opioid that binds to mu-opioid receptors and is partially metabolized to morphine, providing additional analgesic effects. The combination provides synergistic pain relief for moderate pain conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results